Product Code: TMRGL86255
Rapid Microbiology Testing Market - Scope of Report
TMR's report on the global rapid microbiology testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global rapid microbiology testing market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global rapid microbiology testing market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the rapid microbiology testing market.
Market Snapshot |
Market Value in 2023 | US$ 4.1 Bn |
Market Value in 2034 | US$ 7.6 Bn |
CAGR | 5.7% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global rapid microbiology testing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global rapid microbiology testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global rapid microbiology testing market.
The report delves into the competitive landscape of the global rapid microbiology testing market. Key players operating in the global rapid microbiology testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global rapid microbiology testing market profiled in this report.
Key Questions Answered in Global rapid microbiology testing Market Report:
- What is the sales/revenue generated by rapid microbiology testing across all regions during the forecast period?
- What are the opportunities in the global rapid microbiology testing market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Rapid Microbiology Testing Market - Research Objectives and Research Approach
The comprehensive report on the global rapid microbiology testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global rapid microbiology testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global rapid microbiology testing market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Rapid Microbiology Testing Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Rapid Microbiology Testing Market Analysis and Forecasts, 2020-2034
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Value Chain Analysis
- 5.2. Regulatory Scenario by Countries
- 5.3. Key Product/ Brand Analysis
- 5.4. Government Initiatives
- 5.5. Technological Advancements
- 5.6. Key Industry Events
- 5.7. PESTEL Analysis
- 5.8. KOL's Opinion
- 5.9. Unmet Needs
6. Global Rapid Microbiology Testing Market Analysis and Forecasts, By Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast By Product, 2020-2034
- 6.3.1. Instruments
- 6.3.1.1. Automated Microbial Identification System
- 6.3.1.2. PCR
- 6.3.1.3. Mass Spectrometer
- 6.3.1.4. Others
- 6.3.2. Kits and Reagents
- 6.3.3. Software and Services
- 6.4. Market Attractiveness By Product
7. Global Rapid Microbiology Testing Market Analysis and Forecasts, By End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast By End-user, 2020-2034
- 7.3.1. Clinical diagnosis
- 7.3.1.1. Hospitals & Clinics
- 7.3.1.2. Diagnostic Laboratories
- 7.3.2. Industrial Research
- 7.3.2.1. Pharma & Biotech Companies
- 7.3.2.2. Food & Beverages
- 7.3.2.3. Cosmetic
- 7.3.2.4. Environmental Research
- 7.3.2.5. Others
- 7.3.3. Research Application
- 7.3.3.1. CRO & CMO
- 7.3.3.2. Academic & Research Institutes
- 7.4. Market Attractiveness By End-user
8. Global Rapid Microbiology Testing Market Analysis and Forecasts, By Region
- 8.1. Key Findings
- 8.2. Market Value Forecast By Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness By Country/Region
9. North America Rapid Microbiology Testing Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Market Value Forecast By Product, 2020-2034
- 9.2.1. Instruments
- 9.2.1.1. Automated Microbial Identification System
- 9.2.1.2. PCR
- 9.2.1.3. Mass Spectrometer
- 9.2.1.4. Others
- 9.2.2. Kits and Reagents
- 9.2.3. Software and Services
- 9.3. Market Value Forecast By End-user, 2020-2034
- 9.3.1. Clinical diagnosis
- 9.3.1.1. Hospitals & Clinics
- 9.3.1.2. Diagnostic Laboratories
- 9.3.2. Industrial Research
- 9.3.2.1. Pharma & Biotech Companies
- 9.3.2.2. Food & Beverages
- 9.3.2.3. Cosmetic
- 9.3.2.4. Environmental Research
- 9.3.2.5. Others
- 9.3.3. Research Application
- 9.3.3.1. CRO & CMO
- 9.3.3.2. Academic & Research Institutes
- 9.4. Market Value Forecast By Country, 2020-2034
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Product
- 9.5.2. By End-user
- 9.5.3. By Country
10. Europe Rapid Microbiology Testing Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast By Product, 2020-2034
- 10.2.1. Instruments
- 10.2.1.1. Automated Microbial Identification System
- 10.2.1.2. PCR
- 10.2.1.3. Mass Spectrometer
- 10.2.1.4. Others
- 10.2.2. Kits and Reagents
- 10.2.3. Software and Services
- 10.3. Market Value Forecast By End-user, 2020-2034
- 10.3.1. Clinical diagnosis
- 10.3.1.1. Hospitals & Clinics
- 10.3.1.2. Diagnostic Laboratories
- 10.3.2. Industrial Research
- 10.3.2.1. Pharma & Biotech Companies
- 10.3.2.2. Food & Beverages
- 10.3.2.3. Cosmetic
- 10.3.2.4. Environmental Research
- 10.3.2.5. Others
- 10.3.3. Research Application
- 10.3.3.1. CRO & CMO
- 10.3.3.2. Academic & Research Institutes
- 10.4. Market Value Forecast By Country/Sub-region, 2020-2034
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Italy
- 10.4.5. Spain
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Product
- 10.5.2. By End-user
- 10.5.3. By Country/Sub-region
11. Asia Pacific Rapid Microbiology Testing Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast By Product, 2020-2034
- 11.2.1. Instruments
- 11.2.1.1. Automated Microbial Identification System
- 11.2.1.2. PCR
- 11.2.1.3. Mass Spectrometer
- 11.2.1.4. Others
- 11.2.2. Kits and Reagents
- 11.2.3. Software and Services
- 11.3. Market Value Forecast By End-user, 2020-2034
- 11.3.1. Clinical diagnosis
- 11.3.1.1. Hospitals & Clinics
- 11.3.1.2. Diagnostic Laboratories
- 11.3.2. Industrial Research
- 11.3.2.1. Pharma & Biotech Companies
- 11.3.2.2. Food & Beverages
- 11.3.2.3. Cosmetic
- 11.3.2.4. Environmental Research
- 11.3.2.5. Others
- 11.3.3. Research Application
- 11.3.3.1. CRO & CMO
- 11.3.3.2. Academic & Research Institutes
- 11.4. Market Value Forecast By Country/Sub-region, 2020-2034
- 11.4.1. China
- 11.4.2. India
- 11.4.3. Japan
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Product
- 11.5.2. By End-user
- 11.5.3. By Country/Sub-region
12. Latin America Rapid Microbiology Testing Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast By Product, 2020-2034
- 12.2.1. Instruments
- 12.2.1.1. Automated Microbial Identification System
- 12.2.1.2. PCR
- 12.2.1.3. Mass Spectrometer
- 12.2.1.4. Others
- 12.2.2. Kits and Reagents
- 12.2.3. Software and Services
- 12.3. Market Value Forecast By End-user, 2020-2034
- 12.3.1. Clinical diagnosis
- 12.3.1.1. Hospitals & Clinics
- 12.3.1.2. Diagnostic Laboratories
- 12.3.2. Industrial Research
- 12.3.2.1. Pharma & Biotech Companies
- 12.3.2.2. Food & Beverages
- 12.3.2.3. Cosmetic
- 12.3.2.4. Environmental Research
- 12.3.2.5. Others
- 12.3.3. Research Application
- 12.3.3.1. CRO & CMO
- 12.3.3.2. Academic & Research Institutes
- 12.4. Market Value Forecast By Country/Sub-region, 2020-2034
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Product
- 12.5.2. By End-user
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Rapid Microbiology Testing Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast By Product, 2020-2034
- 13.2.1. Instruments
- 13.2.1.1. Automated Microbial Identification System
- 13.2.1.2. PCR
- 13.2.1.3. Mass Spectrometer
- 13.2.1.4. Others
- 13.2.2. Kits and Reagents
- 13.2.3. Software and Services
- 13.3. Market Value Forecast By End-user, 2020-2034
- 13.3.1. Clinical diagnosis
- 13.3.1.1. Hospitals & Clinics
- 13.3.1.2. Diagnostic Laboratories
- 13.3.2. Industrial Research
- 13.3.2.1. Pharma & Biotech Companies
- 13.3.2.2. Food & Beverages
- 13.3.2.3. Cosmetic
- 13.3.2.4. Environmental Research
- 13.3.2.5. Others
- 13.3.3. Research Application
- 13.3.3.1. CRO & CMO
- 13.3.3.2. Academic & Research Institutes
- 13.4. Market Value Forecast By Country/Sub-region, 2020-2034
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Product
- 13.5.2. By End-user
- 13.5.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 14.2. Market Share Analysis By Company (2022)
- 14.3. Company Profiles
- 14.3.1. Biomerieux SA
- 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.1.2. Product Portfolio
- 14.3.1.3. Financial Overview
- 14.3.1.4. SWOT Analysis
- 14.3.1.5. Strategic Overview
- 14.3.2. Becton, Dickinson and Company
- 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.2.2. Product Portfolio
- 14.3.2.3. Financial Overview
- 14.3.2.4. SWOT Analysis
- 14.3.2.5. Strategic Overview
- 14.3.3. Danaher Corporation
- 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.3.2. Product Portfolio
- 14.3.3.3. Financial Overview
- 14.3.3.4. SWOT Analysis
- 14.3.3.5. Strategic Overview
- 14.3.4. Abbott Laboratories
- 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.4.2. Product Portfolio
- 14.3.4.3. Financial Overview
- 14.3.4.4. SWOT Analysis
- 14.3.4.5. Strategic Overview
- 14.3.5. Thermo Fisher Scientific
- 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.5.2. Product Portfolio
- 14.3.5.3. Financial Overview
- 14.3.5.4. SWOT Analysis
- 14.3.5.5. Strategic Overview
- 14.3.6. Merck KGAA
- 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.6.2. Product Portfolio
- 14.3.6.3. Financial Overview
- 14.3.6.4. SWOT Analysis
- 14.3.6.5. Strategic Overview
- 14.3.7. Bruker
- 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.7.2. Product Portfolio
- 14.3.7.3. Financial Overview
- 14.3.7.4. SWOT Analysis
- 14.3.7.5. Strategic Overview
- 14.3.8. Quidelortho Corporation
- 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.8.2. Product Portfolio
- 14.3.8.3. Financial Overview
- 14.3.8.4. SWOT Analysis
- 14.3.8.5. Strategic Overview
- 14.3.9. Sartorius AG
- 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.9.2. Product Portfolio
- 14.3.9.3. Financial Overview
- 14.3.9.4. SWOT Analysis
- 14.3.9.5. Strategic Overview
- 14.3.10. Charles River Laboratories
- 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.10.2. Product Portfolio
- 14.3.10.3. Financial Overview
- 14.3.10.4. SWOT Analysis
- 14.3.10.5. Strategic Overview
- 14.3.11. Neogen Corporation
- 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.11.2. Product Portfolio
- 14.3.11.3. Financial Overview
- 14.3.11.4. SWOT Analysis
- 14.3.11.5. Strategic Overview
- 14.3.12. Bio-Rad
- 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.12.2. Product Portfolio
- 14.3.12.3. Financial Overview
- 14.3.12.4. SWOT Analysis
- 14.3.12.5. Strategic Overview
- 14.3.13. Creative Diagnostics
- 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.13.2. Product Portfolio
- 14.3.13.3. Financial Overview
- 14.3.13.4. SWOT Analysis
- 14.3.13.5. Strategic Overview
- 14.3.14. Hi-Media
- 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.14.2. Product Portfolio
- 14.3.14.3. Financial Overview
- 14.3.14.4. SWOT Analysis
- 14.3.14.5. Strategic Overview
- 14.3.15. Merlin
- 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.15.2. Product Portfolio
- 14.3.15.3. Financial Overview
- 14.3.15.4. SWOT Analysis
- 14.3.15.5. Strategic Overview
- 14.3.16. Zhuhai DL Biotech
- 14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.16.2. Product Portfolio
- 14.3.16.3. Financial Overview
- 14.3.16.4. SWOT Analysis
- 14.3.16.5. Strategic Overview
- 14.3.17. Rapid Micro Biosystems
- 14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.17.2. Product Portfolio
- 14.3.17.3. Financial Overview
- 14.3.17.4. SWOT Analysis
- 14.3.17.5. Strategic Overview
- 14.3.18. Other Prominent Players
- 14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.18.2. Product Portfolio
- 14.3.18.3. Financial Overview
- 14.3.18.4. SWOT Analysis
- 14.3.18.5. Strategic Overview